Schonfeld Strategic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.69M | Buy |
63,060
+35,890
| +132% | +$3.81M | 0.05% | 416 |
|
|
2025
Q1 | $3.37M | Sell |
27,170
-2,147
| -7% | -$267K | 0.02% | 595 |
|
|
2024
Q4 | $3.61M | Sell |
29,317
-65,533
| -69% | -$8.07M | 0.02% | 573 |
|
|
2024
Q3 | $10.6M | Buy |
+94,850
| New | +$10.6M | 0.07% | 231 |
|
|
2024
Q1 | – | Sell |
-4,311
| Closed | -$530K | – | 2030 |
|
|
2023
Q4 | $530K | Buy |
+4,311
| New | +$530K | ﹤0.01% | 1195 |
|
|
2022
Q3 | – | Sell |
-21,099
| Closed | -$3.29M | – | 2969 |
|
|
2022
Q2 | $3.29M | Buy |
+21,099
| New | +$3.29M | 0.03% | 543 |
|
|
2021
Q2 | – | Sell |
-20,531
| Closed | -$3.37M | – | 2062 |
|
|
2021
Q1 | $3.37M | Buy |
+20,531
| New | +$3.37M | 0.04% | 508 |
|
|
2019
Q3 | – | Sell |
-1,489
| Closed | -$212K | – | 1109 |
|
|
2019
Q2 | $212K | Buy |
+1,489
| New | +$212K | 0.01% | 876 |
|
|
2017
Q2 | – | Sell |
-7,402
| Closed | -$1.07M | – | 675 |
|
|
2017
Q1 | $1.07M | Buy |
+7,402
| New | +$1.07M | 0.11% | 246 |
|